Transoral Laser Microsurgery in Recurrent Laryngeal Cancer: A Systematic Review and Meta-analysis.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
06 2023
Historique:
revised: 30 06 2022
received: 24 02 2022
accepted: 05 07 2022
medline: 10 5 2023
pubmed: 9 5 2023
entrez: 9 5 2023
Statut: ppublish

Résumé

To determine the oncological outcomes of salvage transoral laser microsurgery (TLM) in the treatment of patients suffering from recurrent laryngeal cancer. PubMed/MEDLINE, Cochrane Library, and Scopus databases were searched. English language, original studies investigating oncological outcomes of TLM in adult patients with recurrent laryngeal cancer were included. Data were pooled using a distribution-free approach for estimating summary local control (LC), disease-specific survival (DSS), and overall survival (OS) curves with random effects. Two hundred and thirty-five patients underwent salvage TLM after primary (chemo)radiotherapy. The mean follow-up time was 60.8 months (95% CI: 32.7-88.9). Estimated pooled LC rates (95% CI) at 1, 3 and 5 years were 74.2% (61.7-89.4), 53.9% (38.5-75.3), and 39.1% (25.2-60.8). Estimated pooled DSS rates (95% CI) at 1, 3 and 5 years were 88.4% (82.0-95.3), 67.8% (50.9-90.3), and 58.9% (42.7-81.1). Two hundred and seventy-one patients underwent TLM after primary laser treatment. The mean follow-up time was 70.9 months (95% CI: 36.9-104.9). Estimated pooled LC rates (95% CI) at 1, 3 and 5 years were 72.2% (64.7-80.6), 53.2% (42.2-66.9), and 40.4% (29.6-55.2). Estimated pooled DSS rates (95% CI) at 1, 3 and 5 years were 92.1% (85.5-99.1), 77.0% (64.4-92.0), and 67.1% (51.6-87.3). TLM is a valuable treatment option for the management of locally recurrent laryngeal carcinoma if performed by experienced surgeons and following rigorous patients' selection criteria. Further studies should be conducted to define stage-based clinical guidelines. NA Laryngoscope, 133:1425-1433, 2023.

Identifiants

pubmed: 37158265
doi: 10.1002/lary.30332
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1425-1433

Informations de copyright

© 2022 The American Laryngological, Rhinological and Otological Society, Inc.

Références

Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Adv Otorhinolaryngol. 1988;39:135-144. https://doi.org/10.1159/000415662.
Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993;14(2):116-121. https://doi.org/10.1016/0196-0709(93)90050-h.
Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2007;15(2):82-88. https://doi.org/10.1097/MOO.0b013e3280147336.
Peretti G, Piazza C, Cocco D, et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck. 2010;32(8):977-983. https://doi.org/10.1002/hed.21278.
Ansarin M, Cattaneo A, De Benedetto L, et al. Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery. Head Neck. 2017;39(1):71-81. https://doi.org/10.1002/hed.24534.
Hinni ML, Salassa JR, Grant DG, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1198-1204. https://doi.org/10.1001/archotol.133.12.1198.
Rodrigo JP, Kowalski LP, Silver CE, et al. When is reoperative surgery not indicated for recurrent head and neck squamous cell carcinoma? Eur Arch Otorhinolaryngol. 2015 Feb;272(2):259-262. https://doi.org/10.1007/s00405-013-2828-y.
Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000;110(3 Pt 2 Suppl 93):1-18. https://doi.org/10.1097/00005537-200003001-00001.
Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna H, Jones T. Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Cancer. 2011;117(12):2668-2676. https://doi.org/10.1002/cncr.25831.
Deganello A, Gallo O, De Cesare JM, et al. Supracricoid partial laryngectomy as salvage surgery for radiation therapy failure. Head Neck. 2008;30(8):1064-1071. https://doi.org/10.1002/hed.20837.
Holsinger FC, Funk E, Roberts DB, Diaz EM Jr. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck. 2006;28(9):779-784. https://doi.org/10.1002/hed.20415.
Motamed M, Laccourreye O, Bradley PJ. Salvage conservation laryngeal surgery after irradiation failure for early laryngeal cancer. Laryngoscope. 2006;116(3):451-455. https://doi.org/10.1097/01.MLG.0000199591.92336.06.
Ramakrishnan Y, Drinnan M, Kwong FN, et al. Oncologic outcomes of transoral laser microsurgery for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Head Neck. 2014;36(2):280-285. https://doi.org/10.1002/hed.23291.
Meulemans J, Delaere P, Nuyts S, Clement PM, Hermans R, Vander PV. Salvage transoral laser microsurgery for radiorecurrent laryngeal cancer: indications, limits, and outcomes. Curr Otorhinolaryngol Rep. 2017;5(1):83-91. https://doi.org/10.1007/s40136-017-0143-7.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-716.
Efron B. Logistic regression, survival analysis, and the Kaplan-Meier curve. J Am Stat Assoc. 1988;83(402):414-425. https://doi.org/10.2307/2288857.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;7(8):16. https://doi.org/10.1186/1745-6215-8-16.
Combescure C, Foucher Y, Jackson D. Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects. Stat Med. 2014;33(15):2521-2537. https://doi.org/10.1002/sim.6111.
Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101-129. https://doi.org/10.2307/3001666.
Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31(29):3805-3820. https://doi.org/10.1002/sim.5453.
Viechtbauer W, Cheung MWL. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112-125. https://doi.org/10.1002/jrsm.11.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. https://doi.org/10.1136/bmj.315.7109.629.
Ansarin M, Planicka M, Rotundo S, et al. Endoscopic carbon dioxide laser surgery for glottic cancer recurrence after radiotherapy: oncological results. Arch Otolaryngol Head Neck Surg. 2007;133(12):1193-1197. https://doi.org/10.1001/archotol.133.12.1193.
Casiano RR, Cooper JD, Lundy DS, Chandler JR. Laser cordectomy for T1 glottic carcinoma: a 10-year experience and videostroboscopic findings. Otolaryngol Head Neck Surg. 1991;104(6):831-837. https://doi.org/10.1177/019459989110400611.
Forner D, Rigby MH, Corsten M, Trites JR, Pyne J, Taylor SM. Oncological and functional outcomes after repeat transoral laser microsurgery for the treatment of recurrent early glottic cancer. J Laryngol Otol. 2020;21:1-5. https://doi.org/10.1017/S0022215120000407.
Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg. 2008;138(5):606-613. https://doi.org/10.1016/j.otohns.2007.12.046.
Han YJ, Lee HS, Kim SW, et al. Transoral laser microsurgery of recurrent early glottic cancer after radiation therapy: clinical feasibility and limitations. Ann Otol Rhinol Laryngol. 2012;121(6):375-382. https://doi.org/10.1177/000348941212100603.
Huang J, Yu Z, Fang J, Chen X, Chen X, Huang Z. Salvage transoral laser microsurgery for early recurrent glottic carcinoma after primary laser treatment. Acta Otolaryngol. 2013;133(5):531-537. https://doi.org/10.3109/00016489.2012.734929.
Meulemans J, Bijnens J, Delaere P, Vander PV. Up-front and salvage Transoral laser microsurgery for early Glottic squamous cell carcinoma: a single Centre retrospective case series. Front Oncol. 2018;28(8):186. https://doi.org/10.3389/fonc.2018.00186.
Piazza C, Peretti G, Cattaneo A, Garrubba F, De Zinis LO, Nicolai P. Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies. Arch Otolaryngol Head Neck Surg. 2007;133(10):1037-1043. https://doi.org/10.1001/archotol.133.10.1037.
Roedel RM, Matthias C, Wolff HA, Schindler P, Aydin T, Christiansen H. Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic cancer. Auris Nasus Larynx. 2010;37(4):474-481. https://doi.org/10.1016/j.anl.2009.11.004.
Roedel RM, Matthias C, Wolff HA, Christiansen H. Repeated transoral laser microsurgery for early and advanced recurrence of early glottic cancer after primary laser resection. Auris Nasus Larynx. 2010;37(3):340-346. https://doi.org/10.1016/j.anl.2009.07.004.
Steiner W, Vogt P, Ambrosch P, Kron M. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck. 2004;26(6):477-484. https://doi.org/10.1002/hed.20009.
Weiss BG, Bertlich M, Canis M, Ihler F. Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: retrospective analysis of 199 cases. Head Neck. 2017;39(6):1166-1176. https://doi.org/10.1002/hed.24737.
Remacle M, Van Haverbeke C, Eckel H, et al. Proposal for revision of the European laryngological society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol. 2007;264(5):499-504. https://doi.org/10.1007/s00405-007-0279-z. Erratum in: Eur Arch Otorhinolaryngol. 2007;264(6):709.
Viani L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer. 1991;67(3):577-584. https://doi.org/10.1002/1097-0142(19910201)67:3<577::aid-cncr2820670309>3.0.co;2-w.
Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the radiation therapy oncology group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003;129(1):44-49. https://doi.org/10.1001/archotol.129.1.44.
De Virgilio A, Pellini R, Mercante G, et al. Supracricoid partial laryngectomy for radiorecurrent laryngeal cancer: a systematic review of the literature and meta-analysis. Eur Arch Otorhinolaryngol. 2018;275(7):1671-1680. https://doi.org/10.1007/s00405-018-4986-4.
Philippe Y, Espitalier F, Durand N, Ferron C, Bardet E, Malard O. Partial laryngectomy as salvage surgery after radiotherapy: oncological and functional outcomes and impact on quality of life. A retrospective study of 20 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Feb;131(1):15-19. https://doi.org/10.1016/j.anorl.2012.11.008.
Spriano G, Antognoni P, Piantanida R, et al. Conservative management of T1-T2N0 supraglottic cancer: a retrospective study. Am J Otolaryngol. 1997;18(5):299-305. https://doi.org/10.1016/s0196-0709(97)90023-5.
Pellini R, Pichi B, Ruscito P, et al. Supracricoid partial laryngectomies after radiation failure: a multi-institutional series. Head Neck. 2008;30(3):372-379. https://doi.org/10.1002/hed.20709.
Pellini R, Manciocco V, Spriano G. Functional outcome of supracricoid partial laryngectomy with cricohyoidopexy: radiation failure vs previously untreated cases. Arch Otolaryngol Head Neck Surg. 2006;132(11):1221-1225. https://doi.org/10.1001/archotol.132.11.1221.
Marchese-Ragona R, Marioni G, Chiarello G, Staffieri A, Pastore A. Supracricoid laryngectomy with cricohyoidopexy for recurrence of early-stage glottic carcinoma after irradiation. Long-term oncological and functional results. Acta Otolaryngol. 2005 Jan;125(1):91-95. https://doi.org/10.1080/00016480410017927.
León X, López M, García J, Viza I, Orús C, Quer M. Supracricoid laryngectomy as salvage surgery after failure of radiation therapy. Eur Arch Otorhinolaryngol. 2007;264(7):809-814. https://doi.org/10.1007/s00405-007-0259-3.
Peretti G, Piazza C, Mora F, Garofolo S, Guastini L. Reasonable limits for transoral laser microsurgery in laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2016;24(2):135-139. https://doi.org/10.1097/MOO.0000000000000240.
List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer. 1990;66(3):564-569. https://doi.org/10.1002/1097-0142(19900801)66:3<564::aid-cncr2820660326>3.0.co;2-d.
Crosetti E, Caracciolo A, Molteni G, et al. Unravelling the risk factors that underlie laryngeal surgery in elderly. Acta Otorhinolaryngol Ital. 2016;36(3):185-193. https://doi.org/10.14639/0392-100X-817.
Succo G, Crosetti E, Bertolin A, et al. Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: prognostic impact of different pathologic tumor subcategories. Head Neck. 2018;40(9):1897-1908. https://doi.org/10.1002/hed.25176.
Lucioni M, Bertolin A, Lionello M, Giacomelli L, Rizzotto G, Marioni G. Open partial horizontal laryngectomy for salvage after failure of CO₂ laser-assisted surgery for glottic carcinoma. Eur Arch Otorhinolaryngol. 2016;273(1):169-175. https://doi.org/10.1007/s00405-015-3734-2.
Peretti G, Piazza C, Bolzoni A, et al. Analysis of recurrences in 322 tis, T1, or T2 glottic carcinomas treated by carbon dioxide laser. Ann Otol Rhinol Laryngol. 2004;113(11):853-858. https://doi.org/10.1177/000348940411301101.
Jumaily M, Faraji F, Osazuwa-Peters N, Walker RJ, Ward GM. Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma. Oral Oncol. 2019;97:105-111. https://doi.org/10.1016/j.oraloncology.2019.08.005.
Meulemans J, Narimani S, Hauben E, et al. Introduction of a new pathology workup protocol for Glottic cancer treated with Transoral laser microsurgery (TLM): prospective analysis of oncological outcomes and matched case-control study. Front Oncol. 2021;4(11):685255. https://doi.org/10.3389/fonc.2021.685255.

Auteurs

Elena Russo (E)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Andrea Costantino (A)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Maria Vittoria Veneroni (MV)

Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Bianca Maria Festa (BM)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Raul Pellini (R)

Department of Otolaryngology-Head & Neck Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Flaminia Campo (F)

Department of Otolaryngology-Head & Neck Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Gerardo Petruzzi (G)

Department of Otolaryngology-Head & Neck Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Giuseppe Spriano (G)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Giuseppe Mercante (G)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Armando De Virgilio (A)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH